ACET
Price
$2.35
Change
+$0.02 (+0.86%)
Updated
Mar 28, 6:59 PM EST
40 days until earnings call
RARE
Price
$46.69
Change
-$0.13 (-0.28%)
Updated
Mar 28, 6:59 PM EST
34 days until earnings call
Ad is loading...

Analysis and predictions ACET vs RARE

Header iconACET vs RARE Comparison
Open Charts ACET vs RAREBanner chart's image
Adicet Bio
Price$2.35
Change+$0.02 (+0.86%)
Volume$359.98K
CapitalizationN/A
Ultragenyx Pharmaceutical
Price$46.69
Change-$0.13 (-0.28%)
Volume$304.57K
CapitalizationN/A
View a ticker or compare two or three
ACET vs RARE Comparison Chart

Loading...

ACETDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RAREDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACET vs. RARE commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and RARE is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ACET: $2.35 vs. RARE: $46.69)
Brand notoriety: ACET and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 32% vs. RARE: 75%
Market capitalization -- ACET: $193.06M vs. RARE: $3.84B
ACET [@Biotechnology] is valued at $193.06M. RARE’s [@Biotechnology] market capitalization is $3.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 6 TA indicator(s) are bullish while RARE’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 6 bullish, 5 bearish.
  • RARE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACET is a better buy in the short-term than RARE.

Price Growth

ACET (@Biotechnology) experienced а +15.20% price change this week, while RARE (@Biotechnology) price change was +0.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

ACET is expected to report earnings on May 08, 2024.

RARE is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACET with price predictions.
OPEN
A.I.dvisor published
a Summary for RARE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RARE($3.84B) has a higher market cap than ACET($193M). ACET YTD gains are higher at: 24.339 vs. RARE (-2.363). ACET has higher annual earnings (EBITDA): -136.54M vs. RARE (-516.45M). RARE has more cash in the bank: 577M vs. ACET (160M). ACET has less debt than RARE: ACET (20.9M) vs RARE (43.2M). RARE has higher revenues than ACET: RARE (434M) vs ACET (0).
ACETRAREACET / RARE
Capitalization193M3.84B5%
EBITDA-136.54M-516.45M26%
Gain YTD24.339-2.363-1,030%
P/E Ratio6.06N/A-
Revenue0434M-
Total Cash160M577M28%
Total Debt20.9M43.2M48%
FUNDAMENTALS RATINGS
ACET vs RARE: Fundamental Ratings
ACET
RARE
OUTLOOK RATING
1..100
1053
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
4755
P/E GROWTH RATING
1..100
29100
SEASONALITY SCORE
1..100
3620

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (38) in the Medical Distributors industry is in the same range as RARE (70) in the Biotechnology industry. This means that ACET’s stock grew similarly to RARE’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as RARE (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to RARE’s over the last 12 months.

ACET's SMR Rating (97) in the Medical Distributors industry is in the same range as RARE (99) in the Biotechnology industry. This means that ACET’s stock grew similarly to RARE’s over the last 12 months.

ACET's Price Growth Rating (47) in the Medical Distributors industry is in the same range as RARE (55) in the Biotechnology industry. This means that ACET’s stock grew similarly to RARE’s over the last 12 months.

ACET's P/E Growth Rating (29) in the Medical Distributors industry is significantly better than the same rating for RARE (100) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than RARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETRARE
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Ad is loading...
ACETDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RAREDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYE49.400.50
+1.02%
iShares US Energy ETF
CSA69.160.43
+0.62%
VictoryShares US Small Cap Vol Wtd ETF
HDUS50.880.18
+0.35%
Hartford Disciplined US Equity ETF
DDEC37.470.04
+0.10%
FT Cboe Vest US Equity Dp Bfr ETF Dec
YALL33.66-0.23
-0.67%
God Bless America ETF

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+0.86%
OGI - ACET
41%
Loosely correlated
-6.75%
DVAX - ACET
39%
Loosely correlated
N/A
TERN - ACET
39%
Loosely correlated
+6.45%
DCPH - ACET
39%
Loosely correlated
+3.49%
CRON - ACET
36%
Loosely correlated
-3.33%
More